TrialNature2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
David M Hyman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
453 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialNature2018
David M Hyman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.